Streetbeat News

Analyst Ratings

FRSH

Needham analyst Scott Berg has maintained a Buy rating on Freshworks (NASDAQ:FRSH) and increased the price target from $25 to $30.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 11:32 am

LMFA

HC Wainwright & Co. analyst Kevin Dede has initiated coverage on LM Funding America (NASDAQ:LMFA) with a Neutral rating. This new coverage could influence investor perception but does not suggest a strong directional move in the stock price.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 11:18 am

ZVRA

HC Wainwright & Co. analyst Oren Livnat has reaffirmed a Buy rating on Zevra Therapeutics (NASDAQ:ZVRA) and increased the price target from $10 to $15.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 11:13 am

ANY

HC Wainwright & Co. analyst Kevin Dede has initiated coverage on Sphere 3D (NASDAQ:ANY) with a Buy rating and set a price target of $5. This new coverage could influence investor sentiment and potentially impact the stock's performance in the short term.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 11:08 am

MSTR

Canaccord Genuity analyst Joseph Vafi has maintained a Buy rating on MicroStrategy (NASDAQ:MSTR) and increased the price target from $670 to $791.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 10:54 am

CERE

JP Morgan analyst Jessica Fye has maintained a Neutral rating on Cerevel Therapeutics Holdings (CERE) but increased the price target from $25 to $45.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 10:52 am

SAFE

JP Morgan analyst Anthony Paolone has maintained a Neutral rating on Safehold (NYSE:SAFE) and increased the price target from $17 to $23.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 10:47 am

CRON

B of A Securities analyst Lisa Lewandowski has maintained an Underperform rating on Cronos Group (NASDAQ:CRON) but increased the price target from $1.78 to $2.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 10:37 am

KRTX

JP Morgan analyst Jessica Fye has downgraded Karuna Therapeutics (KRTX) from Overweight to Neutral, while also raising the price target from $217 to $330.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 10:24 am

TRV

HSBC analyst Vikram Gandhi has initiated coverage on Travelers Companies (NYSE:TRV) with a Hold rating and set a price target of $203.

Portfolio Pulse from Benzinga Newsdesk

December 28, 2023 | 10:12 am